Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway
Clinical Science · 12.08.2026 · 140 (8) · 1635-1652
DOI: 10.1042/cs20251056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 10.07.2026. Verfasst von Rui Tang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, No.76 Linjiang Road, Yuzhong Distri…. Hauptthemen laut MEDLINE: Clusterin, Wnt Signaling Pathway, Respiratory Distress Syndrome. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Acute respiratory distress syndrome (ARDS) is a critical illness characterized by endothelial barrier damage, and the present study investigates the specific role of clusterin (CLU). The study found that CLU concentrations were significantly lower in ARDS patients, particularly non-survivors, compared with non-ARDS patients and survivors; similarly, serum CLU levels were decreased in mice with lipopolysaccharide-induced ARDS. Both in vivo and in vitro experiments demonstrated that treatment with recombinant CLU protein significantly alleviated organ injury and suppressed the inflammatory response. Mechanistically, CLU improves mitochondrial oxidative phosphorylation by inhibiting the Wnt/β-catenin signaling pathway, thereby inhibiting the expression of inflammatory factors, repairing adherens junctions, and reducing vascular leakage, ultimately preserved intercellular junction protein expression. In summary, CLU ameliorates endothelial injury in ARDS models by inhibiting the Wnt/β-catenin pathway, playing a crucial protective role in host defense against ARDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital of Chongqing Medical University, No.76 Linjiang Road, Yuzhong District, Chongqing 400010, China.
ORCID-Profile: Junnan Peng
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
Zitieren
APA
Tang, R., Tang, W., Hu, H., Peng, J., & Wang, D. (2026). Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway. Clinical Science, 140(8), 1635-1652. https://doi.org/10.1042/cs20251056
Vancouver
Tang R, Tang W, Hu H, Peng J, Wang D. Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway. Clinical Science. 2026;140(8):1635-1652. doi:10.1042/cs20251056
BibTeX
@article{Tang2026,
author = {Tang, Rui and Tang, Wen and Hu, Hao and Peng, Junnan and Wang, Daoxin},
title = {Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway},
journal = {Clinical Science},
year = {2026},
volume = {140},
number = {8},
pages = {1635--1652},
doi = {10.1042/cs20251056}
}
EUVIMED